FRME heads into its May 19 earnings with a striking divergence: options traders have turned sharply bullish even as short interest has quietly rebuilt over the past month.
The options picture is the standout this week. The put/call ratio has collapsed to 0.018 — the lowest reading of the past 52 weeks, well below its 20-day average of 0.20 and more than one standard deviation below that mean. The move appears sharp but sustained: the PCR has held at this extreme level every session since April 20, suggesting a genuine shift in how market participants are positioning on the options side rather than a one-day anomaly. With call activity overwhelming puts, the options market is painting an unusually optimistic picture for a community bank priced at $39.82.
Short interest, however, tells a more cautious story. The headline move this week is a 4% decline in shorts on the week to 2.03% of the free float — but that modest pullback follows a sharp 28% build over the past month. Shorts jumped from around 1.75% in early April to a peak above 2.1% mid-month, before drifting back slightly. Borrow costs remain negligible at 0.57%, and availability is extremely loose — utilisation of the lending pool is only 0.32%, far below the 52-week peak of 3.07% — meaning there is no constraint on new short-selling if sentiment shifts. The borrow market is not signalling a squeeze risk in either direction.
The Street is broadly constructive but not without hesitation. The consensus mean price target of $47.60 implies roughly 19% upside to the current price. Most active analysts have maintained positive ratings — Piper Sandler and KBW both carry Overweight/Outperform ratings. The most recent target action, Piper Sandler raising to $49 in early February, is now nearly three months old. Raymond James downgraded to Market Perform in late September 2025, and their latest standing reflects a more cautious stance on valuation. The valuation itself is undemanding: the P/E runs at 9.2x and price-to-book at 0.87x, with the forward earnings yield near 10.9%. The 30-day expansion in the P/E (roughly 1.2%) reflects the stock's 5% one-month gain before this week's modest pullback. Factor scores show a strong 90th-percentile ranking on forward EPS growth, though the 90-day earnings momentum score of 38 is softer, and the EPS surprise rank at just the 6th percentile suggests the company has a habit of landing roughly in line rather than beating expectations.
Institutional ownership is broad and stable. Vanguard leads with 9.6% of shares, followed by BlackRock at 7.4%. The most recent quarterly changes show incremental additions across the passive holders — State Street added 106,000 shares through March — with no dramatic repositioning visible. Insider activity from February shows a cluster of executive sales at prices in the low-to-mid $42 range, all smaller individual transactions rather than a single large disposal. The net insider figure over 90 days is fractionally positive at roughly 28,000 shares net, though that is heavily influenced by timing.
The Q1 result reported on April 22 produced a 1-day decline of 1.6%, which landed broadly in line with the stock's current week-on-week drift of -1.4%. With the next event set for May 19, the key tension to watch is whether the options-side enthusiasm holds through the month or fades back toward the stock's more moderate short-interest baseline.
See the live data behind this article on ORTEX.
Open FRME on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
